Max Bittrich
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
-
- Peptidase Inhibition and Analysis
- Pancreatic and Hepatic Oncology Research
- CAR-T cell therapy research
Papers in
- Hematology 15
- Multiple Myeloma Research and Treatments 13
- Hematopoietic Stem Cell Transplantation 2
- Acute Myeloid Leukemia Research 2
- Oncology 8
- Cancer Treatment and Pharmacology 2
- Co-authors
- Antonio Giovanni Solimando (6 shared papers)Hermann Einsele (12 shared papers)Andreas Rosenwald (2 shared papers)K. Martin Kortüm (9 shared papers)Markus Krebs (4 shared papers)Andreas Beilhack (4 shared papers)Alexander Kerscher (3 shared papers)Stefan Knop (6 shared papers)
- Journals
- Blood (3 papers)International Journal of Molecular Sciences (3 papers)Journal of Cancer Research and Clinical Oncology (3 papers)Leukemia (1 paper)British Journal of Haematology (1 paper)
- Partner nations
- GermanyItalyUnited States
In The Last Decade
Max Bittrich
20 papers receiving 247 citations
Peers
Comparison fields: 5 of 41
- Hematology 99
- Oncology 119
- Immunology 57
- Immunology and Allergy 13
- Health Informatics 3
Countries citing papers authored by Max Bittrich
This map shows the geographic impact of Max Bittrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Bittrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Bittrich more than expected).
Fields of papers citing papers by Max Bittrich
This network shows the impact of papers produced by Max Bittrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Bittrich. The network helps show where Max Bittrich may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Bittrich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 54 | |
| 2 | 2021 | 34 | |
| 3 | 2015 | 34 | |
| 4 | 2020 | 20 | |
| 5 | 2020 | 14 | |
| 6 | 2018 | 14 | |
| 7 | 2022 | 10 | |
| 8 | 2019 | 10 | |
| 9 | 2022 | 10 | |
| 10 | 2020 | 10 | |
| 11 | 2018 | 10 | |
| 12 | 2023 | 7 | |
| 13 | 2019 | 6 | |
| 14 | 2018 | 4 | |
| 15 | 2023 | 3 | |
| 16 | 2023 | 3 | |
| 17 | 2023 | 3 | |
| 18 | 2018 | 2 | |
| 19 | 2018 | 2 | |
| 20 | 2018 | 1 |
About Max Bittrich
Max Bittrich is a scholar working on Hematology, Oncology, Molecular Biology, Infectious Diseases and Immunology, having authored 20 papers that have together received 251 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (13 papers), Protein Degradation and Inhibitors (6 papers), Cancer Treatment and Pharmacology (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Acute Myeloid Leukemia Research (2 papers), Ubiquitin and proteasome pathways (1 paper), Renal cell carcinoma treatment (1 paper) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Hematology (99 citations), Oncology (119 citations), Immunology (57 citations), Immunology and Allergy (13 citations) and Health Informatics (3 citations). Max Bittrich has collaborated with scholars based in Germany, Italy and United States. Frequent co-authors include Antonio Giovanni Solimando, Hermann Einsele, Andreas Rosenwald, K. Martin Kortüm, Markus Krebs, Andreas Beilhack, Alexander Kerscher, Stefan Knop, Zeinab Mokhtari and Anna Ruckdeschel. Their work appears in journals such as Blood, International Journal of Molecular Sciences, Journal of Cancer Research and Clinical Oncology, Leukemia and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.